Singapore markets closed

Straits Times Index
3,110.73
+36.47(+1.19%)
Nikkei
32,307.86
-550.45(-1.68%)
Hang Seng
16,334.37
-11.52(-0.07%)
FTSE 100
7,554.47
+40.75(+0.54%)
Bitcoin USD
44,326.57
+838.95(+1.93%)
CMC Crypto 200
914.81
+18.10(+2.02%)

Takeda Pharmaceutical Company Limited (TAK)

NYSE - NYSE Delayed Price. Currency in USD

Add to watchlist

14.06

-0.02

(-0.14%)

At close: 04:00PM EST

14.01

-0.05

(-0.36%)

After hours:

06:00PM EST

Trade prices are not sourced from all markets

All

Zacks
Should Value Investors Buy Takeda Pharmaceutical Co. (TAK) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Business Wire
Takeda and The New York Academy of Sciences Announce 2024 Innovators in Science Award Winners
OSAKA, Japan & CAMBRIDGE, Mass., December 05, 2023--Takeda (TSE:4502/NYSE:TAK) and The New York Academy of Sciences today announced the winners of the 2024 Innovators in Science Award for their excellence in, and commitment to, innovative science that has significantly advanced the field of research in cancer immunology. Each winner receives an unrestricted prize of USD 200,000.
Business Wire
Takeda to Present Data at 65th American Society of Hematology (ASH) Annual Meeting, Demonstrating Continued Commitment to Patients with Hematologic Diseases
OSAKA, Japan & CAMBRIDGE, Mass., November 27, 2023--Takeda (TSE:4502/NYSE:TAK) today announced that it will present 17 company-sponsored abstracts at the 65th American Society of Hematology (ASH) Annual Meeting being held December 9-12, 2023 in San Diego. Takeda’s latest research focuses on improving treatment options for those living with hematologic diseases.